Skip to main content
Erschienen in: European Radiology 5/2021

07.11.2020 | Gastrointestinal

Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis: diagnostic performance of CT and MRI

verfasst von: Ji Hye Min, Tae Wook Kang, Yeon-Yoon Kim, Dong Ik Cha, Young Kon Kim, Seong Hyun Kim, Dong Hyun Sinn, Sang Yun Ha, Kyunga Kim

Erschienen in: European Radiology | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To compare the presence of washout and the diagnostic performance of computed tomography (CT) and magnetic resonance imaging (MRI) for hepatocellular carcinoma (HCC) according to the presence of hepatic steatosis.

Methods

This retrospective study included 566 patients with chronic liver disease who had undergone hepatic resection for hepatic tumors (482 HCCs and 84 non-HCCs) between January 2016 and June 2018 and had available multiphasic CT and MR images. Patients were allocated in the fatty liver (n = 141) or non-fatty liver (n = 425) group according to the presence of hepatic steatosis, defined as lipid droplets in at least 5% of hepatocytes on pathological examination. The presence of HCC washout and the diagnostic performance of CT and MRI for HCC were compared between the groups.

Results

HCC washout was less frequently seen in the fatty liver group than in the non-fatty liver group on CT (61.5% vs. 88.9%, p < 0.001), whereas it was similarly present on MRI in both groups (77.0% vs. 74.4%, p = 0.565). For diagnosis of HCC, the sensitivity (53.3% vs. 80.0%, p < 0.001) and accuracy (53.9% vs. 80.9%, p < 0.001) of CT were lower in the fatty liver group than in the non-fatty liver group. However, for MRI, these values were not significantly different between the groups (p > 0.05).

Conclusions

Hepatic steatosis significantly decreased the performance of CT for the diagnosis of HCC, whereas it did not significantly alter the performance of MRI.

Key Points

Unlike MRI, there is vanishing HCC washout on CT caused by the background hepatic steatosis.
The diagnostic performance of CT for the diagnosis of HCC was significantly altered by hepatic steatosis.
The optimal cutoff HU value of the liver parenchyma for the vanishing washout of HCC was < 50 HU on unenhanced CT images.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat European Association for the Study of the Liver (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236 European Association for the Study of the Liver (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236
2.
Zurück zum Zitat Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723–750CrossRef Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723–750CrossRef
3.
Zurück zum Zitat Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358–380CrossRef Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358–380CrossRef
4.
Zurück zum Zitat Korean Liver Cancer Association (KLCA); National Cancer Center (NCC), Goyang, Korea (2019) 2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma. Korean J Radiol 20:1042–1113 Korean Liver Cancer Association (KLCA); National Cancer Center (NCC), Goyang, Korea (2019) 2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma. Korean J Radiol 20:1042–1113
5.
Zurück zum Zitat Omata M, Cheng AL, Kokudo N et al (2017) Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int 11:317–370CrossRef Omata M, Cheng AL, Kokudo N et al (2017) Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int 11:317–370CrossRef
6.
Zurück zum Zitat Santillan C, Fowler K, Kono Y, Chernyak V (2018) LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents. Abdom Radiol (NY) 43:75–81CrossRef Santillan C, Fowler K, Kono Y, Chernyak V (2018) LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents. Abdom Radiol (NY) 43:75–81CrossRef
7.
Zurück zum Zitat Tang A, Bashir MR, Corwin MT et al (2018) Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review. Radiology 286:29–48CrossRef Tang A, Bashir MR, Corwin MT et al (2018) Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review. Radiology 286:29–48CrossRef
8.
Zurück zum Zitat Kitzing YX, Ng BH, Kitzing B et al (2015) Washout of hepatocellular carcinoma on portal venous phase of multidetector computed tomography in a pre-transplant population. J Med Imaging Radiat Oncol 59:673–680CrossRef Kitzing YX, Ng BH, Kitzing B et al (2015) Washout of hepatocellular carcinoma on portal venous phase of multidetector computed tomography in a pre-transplant population. J Med Imaging Radiat Oncol 59:673–680CrossRef
9.
Zurück zum Zitat Min JH, Kim JM, Kim YK et al (2018) Prospective intraindividual comparison of magnetic resonance imaging with gadoxetic acid and extracellular contrast for diagnosis of hepatocellular carcinomas using the Liver Imaging Reporting and Data System. Hepatology 68:2254–2266CrossRef Min JH, Kim JM, Kim YK et al (2018) Prospective intraindividual comparison of magnetic resonance imaging with gadoxetic acid and extracellular contrast for diagnosis of hepatocellular carcinomas using the Liver Imaging Reporting and Data System. Hepatology 68:2254–2266CrossRef
10.
Zurück zum Zitat Rimola J, Forner A, Tremosini S et al (2012) Non-invasive diagnosis of hepatocellular carcinoma </= 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J Hepatol 56:1317–1323CrossRef Rimola J, Forner A, Tremosini S et al (2012) Non-invasive diagnosis of hepatocellular carcinoma </= 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J Hepatol 56:1317–1323CrossRef
11.
Zurück zum Zitat Baffy G, Brunt EM, Caldwell SH (2012) Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 56:1384–1391CrossRef Baffy G, Brunt EM, Caldwell SH (2012) Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 56:1384–1391CrossRef
12.
Zurück zum Zitat Neri E, Bali MA, Ba-Ssalamah A et al (2016) ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents. Eur Radiol 26:921–931CrossRef Neri E, Bali MA, Ba-Ssalamah A et al (2016) ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents. Eur Radiol 26:921–931CrossRef
13.
Zurück zum Zitat Pokharel SS, Macura KJ, Kamel IR, Zaheer A (2013) Current MR imaging lipid detection techniques for diagnosis of lesions in the abdomen and pelvis. Radiographics 33:681–702CrossRef Pokharel SS, Macura KJ, Kamel IR, Zaheer A (2013) Current MR imaging lipid detection techniques for diagnosis of lesions in the abdomen and pelvis. Radiographics 33:681–702CrossRef
14.
Zurück zum Zitat Liu YI, Shin LK, Jeffrey RB, Kamaya A (2013) Quantitatively defining washout in hepatocellular carcinoma. AJR Am J Roentgenol 200:84–89CrossRef Liu YI, Shin LK, Jeffrey RB, Kamaya A (2013) Quantitatively defining washout in hepatocellular carcinoma. AJR Am J Roentgenol 200:84–89CrossRef
15.
Zurück zum Zitat Kim YN, Song JS, Moon WS, Hwang HP, Kim YK (2018) Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI. Acta Radiol 59:639–648CrossRef Kim YN, Song JS, Moon WS, Hwang HP, Kim YK (2018) Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI. Acta Radiol 59:639–648CrossRef
16.
Zurück zum Zitat Sofue K, Sirlin CB, Allen BC, Nelson RC, Berg CL, Bashir MR (2016) How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma. J Magn Reson Imaging 43:1337–1345CrossRef Sofue K, Sirlin CB, Allen BC, Nelson RC, Berg CL, Bashir MR (2016) How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma. J Magn Reson Imaging 43:1337–1345CrossRef
17.
Zurück zum Zitat Li XH, Zhu J, Zhang XM et al (2014) Abdominal MRI at 3.0 T: LAVA-Flex compared with conventional fat suppression T1-weighted images. J Magn Reson Imaging 40:58–66CrossRef Li XH, Zhu J, Zhang XM et al (2014) Abdominal MRI at 3.0 T: LAVA-Flex compared with conventional fat suppression T1-weighted images. J Magn Reson Imaging 40:58–66CrossRef
18.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRef
19.
Zurück zum Zitat Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321CrossRef Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321CrossRef
20.
Zurück zum Zitat Yeh MM, Brunt EM (2014) Pathological features of fatty liver disease. Gastroenterology 147:754–764CrossRef Yeh MM, Brunt EM (2014) Pathological features of fatty liver disease. Gastroenterology 147:754–764CrossRef
21.
Zurück zum Zitat Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS (2005) Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 11:281–289CrossRef Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS (2005) Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 11:281–289CrossRef
22.
Zurück zum Zitat Matsui O (2004) Imaging of multistep human hepatocarcinogenesis by CT during intra-arterial contrast injection. Intervirology 47:271–276CrossRef Matsui O (2004) Imaging of multistep human hepatocarcinogenesis by CT during intra-arterial contrast injection. Intervirology 47:271–276CrossRef
23.
Zurück zum Zitat Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND (1998) Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol 22:656–662CrossRef Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND (1998) Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol 22:656–662CrossRef
24.
Zurück zum Zitat Iannaccone R, Piacentini F, Murakami T et al (2007) Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology 243:422–430CrossRef Iannaccone R, Piacentini F, Murakami T et al (2007) Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology 243:422–430CrossRef
25.
Zurück zum Zitat Rofsky NM, Fleishaker H (1995) CT and MRI of diffuse liver disease. Semin Ultrasound CT MR 16:16–33CrossRef Rofsky NM, Fleishaker H (1995) CT and MRI of diffuse liver disease. Semin Ultrasound CT MR 16:16–33CrossRef
26.
Zurück zum Zitat Koplay M, Sivri M, Erdogan H, Nayman A (2015) Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease. World J Hepatol 7:769–776CrossRef Koplay M, Sivri M, Erdogan H, Nayman A (2015) Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease. World J Hepatol 7:769–776CrossRef
27.
Zurück zum Zitat Lewis E, Bernardino ME, Barnes PA, Parvey HR, Soo CS, Chuang VP (1983) The fatty liver: pitfalls of the CT and angiographic evaluation of metastatic disease. J Comput Assist Tomogr 7:235–241CrossRef Lewis E, Bernardino ME, Barnes PA, Parvey HR, Soo CS, Chuang VP (1983) The fatty liver: pitfalls of the CT and angiographic evaluation of metastatic disease. J Comput Assist Tomogr 7:235–241CrossRef
28.
Zurück zum Zitat Mitchell DG (1992) Focal manifestations of diffuse liver disease at MR imaging. Radiology 185:1–11CrossRef Mitchell DG (1992) Focal manifestations of diffuse liver disease at MR imaging. Radiology 185:1–11CrossRef
29.
Zurück zum Zitat Kato M, Saji S, Kanematsu M et al (1997) A case of liver metastasis from colon cancer masquerading as focal sparing in a fatty liver. Jpn J Clin Oncol 27:189–192CrossRef Kato M, Saji S, Kanematsu M et al (1997) A case of liver metastasis from colon cancer masquerading as focal sparing in a fatty liver. Jpn J Clin Oncol 27:189–192CrossRef
30.
Zurück zum Zitat Chung JJ, Kim MJ, Kim JH, Lee JT, Yoo HS (2003) Fat sparing of surrounding liver from metastasis in patients with fatty liver: MR imaging with histopathologic correlation. AJR Am J Roentgenol 180:1347–1350CrossRef Chung JJ, Kim MJ, Kim JH, Lee JT, Yoo HS (2003) Fat sparing of surrounding liver from metastasis in patients with fatty liver: MR imaging with histopathologic correlation. AJR Am J Roentgenol 180:1347–1350CrossRef
31.
Zurück zum Zitat Baron RL (1994) Understanding and optimizing use of contrast material for CT of the liver. AJR Am J Roentgenol 163:323–331CrossRef Baron RL (1994) Understanding and optimizing use of contrast material for CT of the liver. AJR Am J Roentgenol 163:323–331CrossRef
32.
Zurück zum Zitat Ward J (2006) New MR techniques for the detection of liver metastases. Cancer Imaging 6:33–42CrossRef Ward J (2006) New MR techniques for the detection of liver metastases. Cancer Imaging 6:33–42CrossRef
33.
Zurück zum Zitat Kim SS, Hwang JA, Shin HC et al (2019) LI-RADS v2017 categorisation of HCC using CT: does moderate to severe fatty liver affect accuracy? Eur Radiol 29:186–194CrossRef Kim SS, Hwang JA, Shin HC et al (2019) LI-RADS v2017 categorisation of HCC using CT: does moderate to severe fatty liver affect accuracy? Eur Radiol 29:186–194CrossRef
34.
Zurück zum Zitat Thompson SM, Garg I, Ehman EC et al (2018) Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI. Br J Radiol 91:20180345CrossRef Thompson SM, Garg I, Ehman EC et al (2018) Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI. Br J Radiol 91:20180345CrossRef
35.
Zurück zum Zitat Joo I, Lee JM, Lee DH, Jeon JH, Han JK (2019) Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features? Eur Radiol 29:1724–1732CrossRef Joo I, Lee JM, Lee DH, Jeon JH, Han JK (2019) Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features? Eur Radiol 29:1724–1732CrossRef
36.
Zurück zum Zitat Kim DH, Choi SH, Kim SY, Kim MJ, Lee SS, Byun JH (2019) Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: value of washout in transitional and hepatobiliary phases. Radiology 291:651–657CrossRef Kim DH, Choi SH, Kim SY, Kim MJ, Lee SS, Byun JH (2019) Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: value of washout in transitional and hepatobiliary phases. Radiology 291:651–657CrossRef
Metadaten
Titel
Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis: diagnostic performance of CT and MRI
verfasst von
Ji Hye Min
Tae Wook Kang
Yeon-Yoon Kim
Dong Ik Cha
Young Kon Kim
Seong Hyun Kim
Dong Hyun Sinn
Sang Yun Ha
Kyunga Kim
Publikationsdatum
07.11.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2021
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-07438-9

Weitere Artikel der Ausgabe 5/2021

European Radiology 5/2021 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.